Document is current
Any future updates will be listed below
-
Authors
Ukey, Rahul
Bruiners, Natalie
Mishra, Hridesh
Mishra, Pankaj K.
McCloskey, Deborah
Onyuka, Alberta
Chen, Fei
Pinter, Abraham
Weiskopf, Daniela
Sette, Alessandro
Roy, Jason
Gaur, Sunanda
Gennaro, Maria Laura
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL149450, R01 HL149450-S1)
National Institutes of Health (75N9301900065, 75N9301900065, R61 HD105619, R01 AI158911)
- License Information
-
More Information
Article History
Received: 12 October 2021
Accepted: 11 January 2022
First Online: 25 January 2022
Declarations
:
: The ethics approval was obtained from the Rutgers Institutional Review Board (Pro2020000655). Informed written consent was obtained from each participant before enrollment.
: Consent to publish has been obtained from all the subjects in the study.
: Rutgers University has filed for patent protection for various aspects of anti-SARS-CoV-2 antibody detection and its uses. La Jolla Institute has filed for patent protection for various aspects of T cell epitope and vaccine design work. M.L.G. is a consultant for Biomerieux. A.S. is a consultant for Gritstone, Flow Pharma, Arcturus, Immunoscape, CellCarta, Oxford Immunotec, and Avalia.
